Group 1 - The core viewpoint of the news is that two companies, Jinfang Pharmaceutical-B (02595) and Different Group (06090), are currently in the process of public offering, with significant oversubscription levels reported [1] Group 2 - Jinfang Pharmaceutical-B has received a total of HKD 219.64325 billion in borrowings from various brokers, with an oversubscription rate exceeding 1389 times [1][2] - Different Group has secured HKD 9.3389 billion in borrowings, with an oversubscription rate exceeding 10.9 times [1][2] Group 3 - The total fundraising amount for Jinfang Pharmaceutical-B is HKD 1.58 billion [2] - The total fundraising amount for Different Group is HKD 0.78 billion [2]

| | | 新股仔展 (8月18日) | | | --- | --- | --- | --- | | 新股 | 券商 | | 息率% | | | 辉立 | 24.00 | 0.00 | | | 富途 | 9.79 | 0.00 | | | 信诚 | 3.00 | 0.00 | | | 輝フ | 1.00 - | 0.00 | | 双登股份 | 容す | 0.6557 | 0.00 | | (06960) | 化成 | 0.25 | 0.00 | | | 其他总和 | 7.0706 | | | | 共计 | 45.7663 | | | | | 集资额：0.85亿元 | | | | | 认购:超购逾52.8倍 | | 智通财经APP获悉，双登股份(06960)正在招股中。截止8月18日，富途、辉立、华盛等券商合计为双登股份借出45.7663亿港元，超 购逾52.8倍。 ...